Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

SAVA – Cassava Sciences, Inc.

Float Short %

17.42

Margin Of Safety %

Put/Call OI Ratio

0.24

EPS Next Q Diff

EPS Last/This Y

-1.4

EPS This/Next Y

0.71

Price

2.8

Target Price

8

Analyst Recom

1

Performance Q

33.97

Relative Volume

0.3

Beta

-1.03

Ticker: SAVA



19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2025-11-17SAVA2.790.230.7682805
2025-11-18SAVA2.80.230.0783165
2025-11-19SAVA2.760.230.4383450
2025-11-20SAVA2.630.230.0783820
2025-11-21SAVA2.880.230.0486337
2025-11-24SAVA2.910.220.0777872
2025-11-25SAVA3.040.220.3678748
2025-11-26SAVA3.390.220.2179898
2025-12-01SAVA3.020.220.4179886
2025-12-02SAVA2.880.230.1880876
2025-12-03SAVA3.10.230.2581663
2025-12-04SAVA3.320.230.0783269
2025-12-05SAVA3.180.230.3085169
2025-12-08SAVA3.190.240.7480960
2025-12-09SAVA3.230.250.4381906
2025-12-10SAVA3.260.240.1082157
2025-12-11SAVA3.160.241.0382574
2025-12-12SAVA2.930.250.6983101
2025-12-15SAVA2.810.240.3781253
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1



19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-11-17SAVA2.78- - -1.93
2025-11-18SAVA2.79- - -1.93
2025-11-19SAVA2.75- - -1.93
2025-11-20SAVA2.64- - -1.93
2025-11-21SAVA2.88- - -1.93
2025-11-24SAVA2.91- - -1.93
2025-11-25SAVA3.04- - -1.93
2025-11-26SAVA3.39- - -1.93
2025-12-01SAVA3.03- - -1.93
2025-12-02SAVA2.89- - -1.93
2025-12-03SAVA3.10- - -1.93
2025-12-04SAVA3.33- - -1.93
2025-12-05SAVA3.19- - -1.93
2025-12-08SAVA3.20- - -1.93
2025-12-09SAVA3.24- - -1.93
2025-12-10SAVA3.27- - -1.93
2025-12-11SAVA3.15- - -1.93
2025-12-12SAVA2.93- - -1.93
2025-12-15SAVA2.80- - -1.93
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1



19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-11-17SAVA4.10-1.3617.69
2025-11-18SAVA4.10-1.3617.69
2025-11-19SAVA4.10-1.3617.69
2025-11-20SAVA4.10-1.3617.69
2025-11-21SAVA5.33-1.3617.69
2025-11-24SAVA7.934.5217.69
2025-11-25SAVA7.994.5217.72
2025-11-26SAVA7.994.5217.56
2025-12-01SAVA7.994.6217.62
2025-12-02SAVA7.784.6217.62
2025-12-03SAVA7.784.6217.62
2025-12-04SAVA7.784.6217.62
2025-12-05SAVA7.784.6217.62
2025-12-08SAVA7.784.6217.62
2025-12-09SAVA7.784.6217.62
2025-12-10SAVA7.784.6217.42
2025-12-11SAVA7.784.6217.42
2025-12-12SAVA7.784.6217.42
2025-12-15SAVA7.784.6517.42
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

[stock_market_widget type="chart" template="candlestick" assets="SAVA" range="1y" interval="1d" price_field="close" heading="{symbol}" candle_border_width="1" candle_bullish_background_color="#21BA45" candle_bearish_background_color="#DB2828" candle_bullish_border_color="#21BA45" candle_bearish_border_color="#DB2828" axes_color="#000000" tooltip_text_color="#262626" tooltip_background_color="#ffffff" range_selector="true" volume_enabled="true" axes_enabled="true" tooltip_enabled="false" zoom_enabled="true" save_image_enabled="true" volume_bar_fill_color="#5679FF" api="yahoo-finance"]

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

-0.3

Avg. EPS Est. Next Quarter

-0.31

Insider Transactions

7.78

Institutional Transactions

4.65

Beta

-1.03

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

6

Growth Score

17

Sentiment Score

35

Actual DrawDown %

98.1

Max Drawdown 5-Year %

-99.1

Target Price

8

P/E

Forward P/E

PEG

P/S

P/B

1.66

P/Free Cash Flow

EPS

-2.2

Average EPS Est. Cur. Y​

-1.93

EPS Next Y. (Est.)

-1.22

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.3

Return on Equity vs Sector %

-157

Return on Equity vs Industry %

-141.9

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

[stock_market_widget type=”table-options” template=”gradient” color=”#5679FF” assets=”SAVA” fields=”contract_symbol,type,strike,price,change_pct,implied_volatility,change_abs,open_interest,volume,in_the_money,bid,ask” pagination=”true” rows_per_page=”21″ sort_direction=”asc” alignment=”left” search=”true” sort_field=”strike” api=”yahoo-finance”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”SAVA” options_type=”calls” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”SAVA” options_type=”puts” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”SAVA” options_type=”calls” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”SAVA” options_type=”puts” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”SAVA” options_type=”calls” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”SAVA” options_type=”puts” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
Cassava Sciences, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 30
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. Cassava Sciences, Inc. was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. The company was incorporated in 1998 and is based in Austin, Texas.
stock quote shares SAVA – Cassava Sciences, Inc. Stock Price stock today
news today SAVA – Cassava Sciences, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch SAVA – Cassava Sciences, Inc. yahoo finance google finance
stock history SAVA – Cassava Sciences, Inc. invest stock market
stock prices SAVA premarket after hours
ticker SAVA fair value insiders trading